Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

High regulatory T-cell levels at 1 year posttransplantation predict long-term graft survival among kidney transplant recipients.

San Segundo D, Fernández-Fresnedo G, Rodrigo E, Ruiz JC, González M, Gómez-Alamillo C, Arias M, López-Hoyos M.

Transplant Proc. 2012 Nov;44(9):2538-41. doi: 10.1016/j.transproceed.2012.09.083.

PMID:
23146447
2.

Absolute of CD4(+)CD25(+)FOXP3(+) regulatory T-cell count rather than its ratio in peripheral blood is related to long-term survival of renal allografts.

Liu L, Deng S, Teng L, Fu Q, Wang C, He X.

Transplant Proc. 2012 Jan;44(1):284-6. doi: 10.1016/j.transproceed.2011.12.014.

PMID:
22310634
3.

Low circulating regulatory T-cell levels after acute rejection in liver transplantation.

Demirkiran A, Kok A, Kwekkeboom J, Kusters JG, Metselaar HJ, Tilanus HW, van der Laan LJ.

Liver Transpl. 2006 Feb;12(2):277-84.

4.

Do CD4+ Foxp3+ Treg cells correlate with transplant outcomes: a systematic review on recipients of solid organ transplantation.

Shan J, Guo Y, Luo L, Lu J, Li C, Zhang C, Huang Y, Feng L, Wu W, Long D, Li S, Li Y.

Cell Immunol. 2011;270(1):5-12. doi: 10.1016/j.cellimm.2011.05.006. Epub 2011 May 12. Review.

PMID:
21640985
5.

Pretransplant Recipient Circulating CD4+CD127lo/- Tumor Necrosis Factor Receptor 2+ Regulatory T Cells: A Surrogate of Regulatory T Cell-Suppressive Function and Predictor of Delayed and Slow Graft Function After Kidney Transplantation.

Nguyen MT, Fryml E, Sahakian SK, Liu S, Cantarovich M, Lipman M, Tchervenkov JI, Paraskevas S.

Transplantation. 2016 Feb;100(2):314-24. doi: 10.1097/TP.0000000000000942.

PMID:
26425877
6.

An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients.

Akl A, Jones ND, Rogers N, Bakr MA, Mostafa A, El Shehawy el M, Ghoneim MA, Wood KJ.

Transpl Int. 2008 Jan;21(1):65-73. Epub 2007 Sep 20.

7.

Posttransplant soluble CD30 as a predictor of acute renal allograft rejection.

Kamali K, Abbasi MA, Farokhi B, Abbasi A, Fallah P, Seifee MH, Ghadimi N, Rezaie AR.

Exp Clin Transplant. 2009 Dec;7(4):237-40.

8.

Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.

Wang Z, Xiao L, Shi BY, Qian YY, Bai HW, Chang JY, Cai M.

Transpl Immunol. 2008 Apr;19(1):69-73. doi: 10.1016/j.trim.2008.01.005. Epub 2008 Feb 22.

PMID:
18346640
9.

FOXP3+ regulatory T-cells in renal allografts: correlation with long-term graft function and acute rejection.

Kollins D, Stoelcker B, Hoffmann U, Bergler T, Reinhold S, Banas MC, Rümmele P, Farkas S, Krämer BK, Banas B.

Clin Nephrol. 2011 Feb;75(2):91-100.

PMID:
21255537
10.

Fetuin-A pretransplant serum levels, kidney allograft function and rejection episodes: a 3-year posttransplantation follow-up.

Roos M, Heinemann FM, Lindemann M, Horn PA, Lutz J, Stock K, Thürmel K, Baumann M, Witzke O, Heemann U.

Kidney Blood Press Res. 2011;34(5):328-33. doi: 10.1159/000327848. Epub 2011 May 26.

11.

Correlation of immunological markers with graft vasculopathy development in heart transplantation.

Roldán C, Mirabet S, Brossa V, Moltó E, Lopez L, Alvaro Y, Sole E, Padró JM, Gelpí C, Roig E.

Transplant Proc. 2012 Nov;44(9):2653-6. doi: 10.1016/j.transproceed.2012.09.048.

PMID:
23146484
12.

The role of Foxp3+ regulatory T cells in kidney transplantation.

Karczewski M, Karczewski J, Kostrzewa A, Wiktorowicz K, Glyda M.

Transplant Proc. 2009 Jun;41(5):1527-9. doi: 10.1016/j.transproceed.2009.03.065.

PMID:
19545671
13.
14.

Pretransplantation recipient regulatory T cell suppressive function predicts delayed and slow graft function after kidney transplantation.

Nguyen MT, Fryml E, Sahakian SK, Liu S, Michel RP, Lipman ML, Mucsi I, Cantarovich M, Tchervenkov JI, Paraskevas S.

Transplantation. 2014 Oct 15;98(7):745-53. doi: 10.1097/TP.0000000000000219.

PMID:
24879386
15.

Alemtuzumab induction in kidney transplantation: clinical results and impact on T-regulatory cells.

Morales J, Bono MR, Fierro A, Iñiguez R, Zehnder C, Rosemblatt M, Calabran L, Herzog C, Benavente D, Aguiló J, Pefaur J, Alba A, Ferrario M, Simon W, Contreras L, Buckel E.

Transplant Proc. 2008 Nov;40(9):3223-8. doi: 10.1016/j.transproceed.2008.03.066.

PMID:
19010240
16.

Early posttransplantation hyperglycemia in kidney transplant recipients is associated with overall long-term graft losses.

Valderhaug TG, Hjelmesæth J, Jenssen T, Røislien J, Leivestad T, Hartmann A.

Transplantation. 2012 Oct 15;94(7):714-20. doi: 10.1097/TP.0b013e31825f4434.

PMID:
22965263
17.

Very early serum creatinine as a surrogate marker for graft survival beyond 10 years.

Pascual J, Marcén R, Zamora J, Fernández AM, Burgos FJ, Villafruela JJ, Ortuño J.

J Nephrol. 2009 Jan-Feb;22(1):90-8.

PMID:
19229823
18.

Different regulatory and cytotoxic CD4+ T lymphocyte profiles in renal transplants with antibody-mediated chronic rejection or long-term good graft function.

Giaretta F, Bussolino S, Beltramo S, Fop F, Rossetti M, Messina M, Cantaluppi V, Ranghino A, Basso E, Camussi G, Segoloni GP, Biancone L.

Transpl Immunol. 2013 Jan;28(1):48-56. doi: 10.1016/j.trim.2012.11.003. Epub 2012 Nov 22.

PMID:
23178518
19.

Advantages of kidney transplant precocity in graft long-term survival.

Malho A, Malheiro J, Fonseca I, Martins LS, Pedroso S, Almeida M, Dias L, Castro Henriques A, Cabrita A.

Transplant Proc. 2012 Oct;44(8):2344-7. doi: 10.1016/j.transproceed.2012.07.030.

PMID:
23026589
20.

Clinical significance of regulatory T-cell-related gene expression in peripheral blood after renal transplantation.

Iwase H, Kobayashi T, Kodera Y, Miwa Y, Kuzuya T, Iwasaki K, Haneda M, Katayama A, Takeda A, Morozumi K, Watarai Y, Uchida K, Nakao A.

Transplantation. 2011 Jan 27;91(2):191-8. doi: 10.1097/TP.0b013e3181ffbab4.

PMID:
21157405

Supplemental Content

Support Center